Chronic cerebral hypoperfusion-induced impairment of Aβ clearance requires HB-EGF-dependent sequential activation of HIF1α and MMP9

Neurobiology of Disease

Volumn 95, Issue , 2016, Pages 179-193

  Ashok, Anushruti ^a,b   Rai, Nagendra Kumar ^a,b   Raza, Waseem ^b   Pandey, Rukmani ^a,b   Bandyopadhyay, Sanghamitra ^a,b  

^a ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

^b CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

AD; BBB; BCCAO; HB EGF; LRP 1; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; GELATINASE B; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; AMYLOID PRECURSOR PROTEIN; HIF1A PROTEIN, MOUSE; MMP9 PROTEIN, MOUSE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BLOOD BRAIN BARRIER; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; COMMON CAROTID ARTERY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PASSIVE AVOIDANCE TEST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; UPREGULATION; WESTERN BLOTTING; Y-MAZE TEST; ANIMAL; BRAIN ISCHEMIA; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PERFUSION; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MATRIX METALLOPROTEINASE 9; MICE; PERFUSION; RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS;

EID: 84979234401     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2016.07.013     Document Type: Article

References (63)

1. Asakura, M., et al. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 8 (2002), 35–40.
2. Ashok, A., et al. Exposure to As-, Cd-, and Pb-mixture induces Abeta, amyloidogenic APP processing and cognitive impairments via oxidative stress-dependent neuroinflammation in young rats. Toxicol. Sci. 143 (2015), 64–80.
3. Baeten, K.M., Akassoglou, K., Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke. Dev. Neurobiol. 71 (2011), 1018–1039.
4. Bandyopadhyay, S., et al. Interleukin-1alpha stimulates non-amyloidogenic pathway by alpha-secretase (ADAM-10 and ADAM-17) cleavage of APP in human astrocytic cells involving p38 MAP kinase. J. Neurosci. Res. 84 (2006), 106–118.
5. Biron, K.E., et al. Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease. PLoS One, 6, 2011, e23789.
6. Cartharius, K., et al. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21 (2005), 2933–2942.
7. Chen, L., et al. Endophilin-1 regulates blood-brain barrier permeability via EGFR-JNK signaling pathway. Brain Res. 1606 (2015), 44–53.
8. Cockayne, D.A., et al. Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity. PLoS One, 7, 2012, e38629.
9. da Costa, N.M., et al. Role of hypoxia-related proteins in invasion of ameloblastoma cells: crosstalk between NOTCH1, HIF-1alpha, ADAM-12, and HB-EGF. Histopathology, 2015.
10. de la Torre, J.C., Vascular basis of Alzheimer's pathogenesis. Ann. N. Y. Acad. Sci. 977 (2002), 196–215.
11. Deane, R., et al. The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease. Curr. Pharm. Des. 14 (2008), 1601–1605.
12. Deane, R., et al. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS Neurol. Disord. Drug Targets 8 (2009), 16–30.
13. Fechner, G., et al. Evaluation of hypoxia-mediated growth factors in a novel bladder cancer animal model. Anticancer Res. 27 (2007), 4225–4231.
14. Garcia-Osta, A., Alberini, C.M., Amyloid beta mediates memory formation. Learn. Mem. 16 (2009), 267–272.
15. Grammas, P., et al. Brain microvasculature and hypoxia-related proteins in Alzheimer's disease. Int. J. Clin. Exp. Pathol. 4 (2011), 616–627.
16. Jahn, H., Memory loss in Alzheimer's disease. Dialogues Clin. Neurosci. 15 (2013), 445–454.
17. Jensen, E.C., Quantitative analysis of histological staining and fluorescence using ImageJ. Anat. Rec. (Hoboken) 296 (2013), 378–381.
18. Jeynes, B., Provias, J., Evidence for altered LRP/RAGE expression in Alzheimer lesion pathogenesis. Curr. Alzheimer Res. 5 (2008), 432–437.
19. Jiang, B.H., et al. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271 (1996), 17771–17778.
20. Jin, K., et al. Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo. J. Neurosci. 22 (2002), 5365–5373.
21. Jin, K., et al. Post-ischemic administration of heparin-binding epidermal growth factor-like growth factor (HB-EGF) reduces infarct size and modifies neurogenesis after focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 24 (2004), 399–408.
22. Kawahara, N., et al. The gene for heparin-binding epidermal growth factor-like growth factor is stress-inducible: its role in cerebral ischemia. J. Cereb. Blood Flow Metab. 19 (1999), 307–320.
23. Lakhan, S.E., et al. Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. Front. Neurol., 4, 2013, 32.
24. Li, J., et al. Altered expression of hypoxia-inducible factor-1alpha participates in the epileptogenesis in animal models. Synapse 68 (2014), 402–409.
25. Liu, L., Duff, K., A technique for serial collection of cerebrospinal fluid from the cisterna magna in mouse. J. Vis. Exp., 2008.
26. Liu, H., et al. Regulation of beta-amyloid level in the brain of rats with cerebrovascular hypoperfusion. Neurobiol. Aging 33:826 (2012), e31–e42.
27. Mandillo, S., et al. Reliability, robustness, and reproducibility in mouse behavioral phenotyping: a cross-laboratory study. Physiol. Genomics 34 (2008), 243–255.
28. Marquez-Martin, A., et al. Middle cerebral artery alterations in a rat chronic hypoperfusion model. J. Appl. Physiol. (1985) 112 (2012), 511–518.
29. Martin, R., et al. Secreted phospholipase A2-IIA-induced a phenotype of activated microglia in BV-2 cells requires epidermal growth factor receptor transactivation and proHB-EGF shedding. J. Neuroinflammation, 9, 2012, 154.
30. Maurya, S.K., et al. Cypermethrin induces astrocyte apoptosis by the disruption of the autocrine/paracrine mode of epidermal growth factor receptor signaling. Toxicol. Sci. 125 (2012), 473–487.
31. Maurya, S.K., et al. Cypermethrin induces astrocyte damage: role of aberrant Ca(2 +), ROS, JNK, P38, matrix metalloproteinase 2 and migration related reelin protein. Pestic. Biochem. Physiol. 111 (2014), 51–59.
32. Maurya, S.K., et al. Cypermethrin stimulates GSK3beta-dependent Abeta and p-tau proteins and cognitive loss in young rats: reduced HB-EGF signaling and downstream neuroinflammation as critical regulators. Mol. Neurobiol., 2015.
33. Miki, K., et al. Intensity of chronic cerebral hypoperfusion determines white/gray matter injury and cognitive/motor dysfunction in mice. J. Neurosci. Res. 87 (2009), 1270–1281.
34. Nunan, J., Small, D.H., Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Lett. 483 (2000), 6–10.
35. Oyagi, A., et al. Generation and characterization of conditional heparin-binding EGF-like growth factor knockout mice. PLoS One, 4, 2009, e7461.
36. Oyagi, A., et al. Forebrain specific heparin-binding epidermal growth factor-like growth factor knockout mice show exacerbated ischemia and reperfusion injury. Neuroscience 185 (2011), 116–124.
37. Ozeki, K., et al. Telmisartan inhibits cell proliferation by blocking nuclear translocation of ProHB-EGF C-terminal fragment in colon cancer cells. PLoS One, 8, 2013, e56770.
38. Quesseveur, G., et al. BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities. Transl. Psychiatry, 3, 2013, e253.
39. Rai, A., et al. Characterization of developmental neurotoxicity of as, Cd, and Pb mixture: synergistic action of metal mixture in glial and neuronal functions. Toxicol. Sci. 118 (2010), 586–601.
40. Rai, N.K., et al. Exposure to As, Cd and Pb-mixture impairs myelin and axon development in rat brain, optic nerve and retina. Toxicol. Appl. Pharmacol. 273 (2013), 242–258.
41. Rai, A., et al. CDK5-induced p-PPARgamma(Ser 112) downregulates GFAP via PPREs in developing rat brain: effect of metal mixture and troglitazone in astrocytes. Cell Death Dis., 5, 2014, e1033.
42. Rius, J., et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453 (2008), 807–811.
43. Sastre, M., et al. Interactions between APP secretases and inflammatory mediators. J. Neuroinflammation, 5, 2008, 25.
44. Schiavon, A.P., et al. Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice. Neurotox. Res. 26 (2014), 307–316.
45. Schonenberger, M.J., Kovacs, W.J., Hypoxia signaling pathways: modulators of oxygen-related organelles. Front. Cell Dev. Biol., 3, 2015, 42.
46. Selkoe, D.J., Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease. Neurobiol. Aging 10 (1989), 387–395.
47. Selkoe, D.J., Normal and abnormal biology of the beta-amyloid precursor protein. Annu. Rev. Neurosci. 17 (1994), 489–517.
48. Shah, B.H., et al. Role of metalloproteinase-dependent EGF receptor activation in alpha-adrenoceptor-stimulated MAP kinase phosphorylation in GT1-7 neurons. J. Neurochem. 96 (2006), 520–532.
49. Silverberg, G.D., et al. Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging. J. Neuropathol. Exp. Neurol. 69 (2010), 98–108.
50. Soares, L.M., et al. Cognitive impairment and persistent anxiety-related responses following bilateral common carotid artery occlusion in mice. Behav. Brain Res. 249 (2013), 28–37.
51. Sobow, T., et al. Amyloid-beta and tau proteins as biochemical markers of Alzheimer's disease. Acta Neurobiol. Exp. (Wars) 64 (2004), 53–70.
52. Tanaka, N., et al. Heparin-binding epidermal growth factor-like growth factor mRNA expression in neonatal rat brain with hypoxic/ischemic injury. Brain Res. 827 (1999), 130–138.
53. Tian, W., Kyriakides, T.R., Matrix metalloproteinase-9 deficiency leads to prolonged foreign body response in the brain associated with increased IL-1beta levels and leakage of the blood-brain barrier. Matrix Biol. 28 (2009), 148–159.
54. Verma, R.P., Hansch, C., Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. Bioorg. Med. Chem. 15 (2007), 2223–2268.
55. Wang, P., et al. CRM197-induced blood-brain barrier permeability increase is mediated by upregulation of caveolin-1 protein. J. Mol. Neurosci. 43 (2011), 485–492.
56. Wang, Z., et al. Potential contribution of hypoxia-inducible factor-1alpha, aquaporin-4, and matrix metalloproteinase-9 to blood-brain barrier disruption and brain edema after experimental subarachnoid hemorrhage. J. Mol. Neurosci. 48 (2012), 273–280.
57. Xu, K.P., et al. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 45 (2004), 813–820.
58. Xu, Q., et al. Sigma 1 receptor activation regulates brain-derived neurotrophic factor through NR2A-CaMKIV-TORC1 pathway to rescue the impairment of learning and memory induced by brain ischaemia/reperfusion. Psychopharmacology 232 (2015), 1779–1791.
59. Yadav, R.S., et al. Neuroprotective efficacy of curcumin in arsenic induced cholinergic dysfunctions in rats. Neurotoxicology 32 (2011), 760–768.
60. Yang, Y., et al. Changes in levels of hypoxia-induced mediators in rat hippocampus during chronic cerebral hypoperfusion. Neurochem. Res. 38 (2013), 2433–2439.
61. Yotsumoto, F., et al. Molecular hierarchy of heparin-binding EGF-like growth factor-regulated angiogenesis in triple-negative breast cancer. Mol. Cancer Res. 11 (2013), 506–517.
62. Zhang, X., et al. Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J. Biol. Chem. 282 (2007), 10873–10880.
63. Zhiyou, C., et al. Upregulation of BACE1 and beta-amyloid protein mediated by chronic cerebral hypoperfusion contributes to cognitive impairment and pathogenesis of Alzheimer's disease. Neurochem. Res. 34 (2009), 1226–1235.